What is the KAPA stock price prediction for next 2 weeks?

According to our price prediction algorithm,Kairos Pharma, Ltd. (KAPA) price will be around $0.28 in the next 2 weeks. This means it will decrease by -12.9245283018868 from the last closing price. This prediction may vary from other time period filters for KAPA stock.

What can be the highest Possible price of KAPA stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, KAPA can achieve the highest price of $0.30 which is -5.464603581224145 lower than last closing price. This prediction may vary from other time period filters for KAPA stock.

What can be the lowest Possible price of KAPA stock in next 2 weeks?

As per the forecast and algorithmic analysis, KAPA stock price can be as low as $0.25 which is -20.09131178377095 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for KAPA stock.

Will KAPA stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that KAPA stock will lose-12.9245283018868 in the next 2 weeks. This prediction may vary from other time period filters for KAPA stock.

What is KAPA stock last closing price?

Last closing price of KAPA stock was $0.34.

What is KAPA stock price prediction?

KAPA stock price prediction means predicting the future closing prices of KAPA stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of KAPA stock in a certain time period.

How we predict KAPA stock future prices?

If you are searching for KAPA stock forecast, analysis or price prediction, then you might be wondering what Kairos Pharma, Ltd. (KAPA) will do in the future. Our KAPA price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This KAPA price prediction will likely answer most of your questions.

How frequent we update KAPA stock predictions?

We are updating the forecasts for the KAPA stock on daily basis.

Is using ML forecasting for KAPA stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for KAPA stock same for all the time periods?

No, the prediction for KAPA stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Kairos Pharma, Ltd. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.34-8.16%Since 2 Weeks

Predicted Price$0.28-12.92%For 2 Weeks

Upper Predicted Price$0.30-5.46%For 2 Weeks

Lower Predicted Price$0.25-20.09%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of KAPA will decline by -12.92% over the next 2 Weeks and hit $0.28 by Wednesday, July 29, 2026. In that time frame, KAPA's share price is expected to range between $0.25 and $0.30.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 29, 2026	0.25	0.28	0.30
Jul 28, 2026	0.26	0.28	0.31
Jul 27, 2026	0.27	0.29	0.31
Jul 24, 2026	0.26	0.28	0.30
Jul 23, 2026	0.28	0.30	0.32
Jul 22, 2026	0.28	0.30	0.32
Jul 21, 2026	0.29	0.31	0.33
Jul 20, 2026	0.29	0.31	0.33
Jul 17, 2026	0.29	0.31	0.33
Jul 16, 2026	0.30	0.32	0.34

KAPA shares rose +6.89% in Thursday, July 16, 2026's trading session, rising from a previous close of $0.32 to move at $0.34. The stock demonstrated notable intraday movement (see KAPA's key stats for a full breakdown), fluctuating between $0.33 and $0.37, a +12.46% trading range. While recent weeks have seen some volatility, KAPA has managed to secure a -8.16% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 45.67M shares changing hands, 32.34M more than the previous session. This amounted to $15.52M in total market activity.

Will KAPA Continue Its Downward Trend?

According to analyst ratings and projections for KAPA, Kairos Pharma, Ltd. shares are anticipated to decrease by -13.07%, potentially reaching $0.30 per share by July 29, 2026. Short-term technical indicators currently suggest a neutral sentiment for KAPA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the KAPA stock forecast, now is not the best time to buy KAPA stock because its current trading price is +22.75% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KAPA covering social and institutional perspectives.

KAPA Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into KAPA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.75% to 38.32%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 40.04%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.52%, maintains a neutral outlook for the long term. Insights into KAPA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Kairos Pharma Short-Term Forecasts

KAPA Forecast For Next 5 Days

Our algorithm anticipates Kairos Pharma (KAPA) stock could hit $0.30 by Jul 23, 2026. This represents a -10.53% fall from today's price, following a -0.57% change over the past five days.

KAPA Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Kairos Pharma, Ltd. (KAPA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.26, which would mean a -23.51% decrease from the current price of $0.34. Projections for this period range from a high of $0.36 to a low of $0.18.

KAPA Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Kairos Pharma's price over the next three months point to a rise. KAPA stock is expected to peak at $4.74 on Sep 07, 2026 before potentially dipping to $2.48 on Oct 16, 2026. On average, KAPA is likely to trade around $3.67 in the coming 90 days.

Kairos Pharma Stock Forecast 2025

Based on our predictive models, Kairos Pharma (KAPA) is expected to trade between $1.55 and $4.74 throughout 2026. This would result in an average price of $3.36, potentially offering investors a +888.53% return from current levels.

Kairos Pharma, Ltd. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in July 2026. The price is predicted to move between $2.91 and $4.02, settling at an average of $3.68. This could translate to a +982.67% gain.

August 2026

Based on current market signals, Kairos Pharma, Ltd. is projected to trend august 2026. We forecast a trading range from $3.49 to $4.65, with a likely average price of $4.12. Investors could expect a potential return of +1,112.12%.

September 2026

Our predictive algorithms indicate Kairos Pharma, Ltd. stock may see a shift in September 2026. The expected range spans $2.64–$4.74, with an average target of $3.68. This represents a positive outlook and a possible gain of +982.67%.

October 2026

Analyzing established trends, Kairos Pharma, Ltd. looks set to move in October 2026. Projections place the stock between $2.29 and $3.29, averaging around $2.85. This suggests a +738.48% gain from current levels.

November 2026

Market indicators suggest Kairos Pharma, Ltd. could experience notable changes during November 2026. Prices could fluctuate within $1.55 to $3.73, with a midpoint forecast of $2.84. The stock might deliver a +735.54% gain.

December 2026

Forecasting for December 2026, models estimate that Kairos Pharma, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $1.91 and $4.39, averaging $3.16. This signals a positive trajectory with potential returns around +829.69%.

January 2027

According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in January 2027. The price is predicted to move between $1.94 and $5.64, settling at an average of $4.62. This could translate to a +1,259.22% gain.

February 2027

Based on current market signals, Kairos Pharma, Ltd. is projected to trend february 2027. We forecast a trading range from $1.27 to $4.09, with a likely average price of $3.34. Investors could expect a potential return of +882.64%.

March 2027

Our predictive algorithms indicate Kairos Pharma, Ltd. stock may see a shift in March 2027. The expected range spans $1.02–$4.95, with an average target of $3.83. This represents a positive outlook and a possible gain of +1,026.80%.

April 2027

Analyzing established trends, Kairos Pharma, Ltd. looks set to move in April 2027. Projections place the stock between $0.40 and $5.52, averaging around $4.21. This suggests a +1,138.60% gain from current levels.

May 2027

Market indicators suggest Kairos Pharma, Ltd. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $4.20, with a midpoint forecast of $3.36. The stock might deliver a +888.53% gain.

June 2027

Forecasting for June 2027, models estimate that Kairos Pharma, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.42, averaging $3.24. This signals a positive trajectory with potential returns around +853.22%.

July 2027

According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $2.48, settling at an average of $1.83. This could translate to a +438.39% gain.

KAPA's history of dividends and stock splits also plays a role in long-term investor confidence.